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Mesenchymal stem cells (MSCs) hold a great promise for cell therapy. To date, they
represent one of the best choices for the treatment of post-traumatic injuries of the
peripheral nervous system. Although autologous can be easily transplanted in the injured
area, clinical advances in this filed have been impaired by lack of preservation of graft cells
into the injury area after transplantation. Indeed, cell viability is not retained after injection
into the blood stream, and cells injected directly into the area of injury either are washed
off or inhibit regeneration through scar formation and neuroma development. This study
proposes a new way of MSCs delivery to the area of traumatic injury by using fibrin
glue, which not only fixes cells at the site of application but also provides extracellular
matrix support. Using a sciatic nerve injury model, MSC derived from adipose tissue
embedded in fibrin glue were able to enter the nerve and migrate mainly retrogradely after
transplantation. They also demonstrated a neuroprotective effect on DRG L5 sensory
neurons and stimulated axon growth and myelination. Post-traumatic changes of the
sensory neuron phenotype were also improved. Importantly, MSCs stimulated nerve
angiogenesis andmotor function recovery. Therefore, our data suggest that MSC therapy
using fibrin glue is a safe and efficient method of cell transplantation in cases of sciatic
nerve injury, and that this method of delivery of regeneration stimulants could be beneficial
for the successful treatment of other central and peripheral nervous system conditions.
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INTRODUCTION
Peripheral neuropathy caused by trauma and prevalent disorders is a major medical problem
worldwide. Due to anatomy of the peripheral nervous system, structure damage of peripheral
nerve trunks is a rather common condition. Although nerve trunk injury is not a life-threatening
condition, it is accompanied by a persistent complex of nociceptive, sensory, and motor as well
as trophic changes that can result in long-lasting disability, with full recovery of lost extremity
functions being difficult (1, 2). Therefore, new translational research is focusing on combined
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methods of tissue engineering and replacement cell therapy along
with the advancements in microsurgical techniques to enable
efficient restoration of damaged peripheral nerves in clinical
practice (3–8).
When facilitating nerve structure recovery to reduce nerve
tissue injury, the main focus is to use various organic glues that
join the ends of the damaged nerve (9) or are part of nerve
conduit (10). The use of fibrin glue is particularly promising as it
has been shown to be non-invasive and not causing inflammation
or granuloma formation in post-traumatic nerve reconstruction
(11–13). Fibrin glue can also induce faster re-innervation and
function recovery due to reduced amount of scar tissue and
directed axon growth (14, 15).
After nerve injury, the release of pro-inflammatory cytokines
causes fibroblast activation and collagen hyperplasia leading to
scars, fibrosis, and neuroma formation. These pro-inflammatory
and nerve growth factors are necessary for axon regeneration
by maintaining the balance between collagen synthesis and
degradation without inducing fibroblast activation (16).
Therefore, targeted delivery of potential neurorestoration
stimulants is extremely important and cell therapy can be used
to accelerate axon growth and help sensory neurons to survive
(17, 18). To this end, mesenchymal stem cells (MSCs) have
been most widely used (19) as an autologous system able to
stimulate nerve tissue regeneration by neurotrophic growth
factor secretion (20) and guided differentiation to the neuronal
and glial lineages (21, 22).
MSCs can replace damaged tissues, secrete biologically active
compounds, including homing and signaling molecules as well
as myelin components necessary for structural and functional
recovery of nerve fibers (23). Importantly, they do not cause
immune rejection after allogeneic transplantation (24). MSCs can
be easily derived from various tissues and expanded in culture. A
useful source is the adipose tissue as adipose derived stem cells
(ADSCs) have demonstrated MSCs properties (19, 25), together
with ease of availability, derivation, and safety (26).
In order to attain efficient regeneration, transplanted cells
need to survive and function in the area of injury. Cell survival
after their injection is influenced by many factors, including
speed of cell injection, cell density and diameter of the needle
(27, 28). Regardless of the method used to assess the survival rate,
cell type, and transplantation model, it is widely accepted that
only a small portion of transplanted cells survive after injection
(29, 30). Indeed, cells can be lost in the systemic circulation, but
also local cell delivery by injection can cause additional damage
and lead to neuroma development (31). Therefore, it is necessary
to address a number of key issues to improve local cell retention
in the area of injury before cell therapy can become a viable
treatment option for peripheral nerve injury. In this study, we
used fibrin glue for cell delivery. This formulation demonstrates
several advantages, being minimally invasive, helping to retain
cells in the area of injury, providing cells with extracellular matrix
support and additional physical connection of the nerve ends
(glue effect). We show that transplantation of MSCs embedded
in fibrin glue promotes regeneration through a neuroprotective
effect on sensory neurons and stimulation of axon growth. We
also demonstrate for the first time a positive effect on recovery
of motor function after injury, thus paving the way for the use of
fibrin glue and MSC cell therapy in the treatment of peripheral
nerve damage.
MATERIALS AND METHODS
MSC Derivation and Culture
MSC (ADSCs) were derived from the inguinal fold subcutaneous
adipose tissue of healthy female Wistar rats (n= 5), as previously
described (32). Subcutaneous fat tissue from different animals
was obtained in equal volumes and immediately mixed for
subsequent cultivation. Adipose tissue enzymatic disaggregation
was achieved by incubation with type 1 collagenase (Biolot,
Russia) at 37◦C on a shaker for 1 h. Before and after the
incubation the tissue was washed three times by centrifugation
at 500 rpm for 5min with DPBS solution (Dulbecco‘s Phosphate
Buffered Saline, Paneco, Russia) containing 5% of penicillin
and 5% of streptomycin. The cell pellet was resuspended and
plated in culture in αMEM (Alpha Minimum Essential Medium,
Invitrogen, USA) with 10% of FBS (Fetal Bovine Serum, Sigma,
USA). Cultures were cultured and expanded in αMEM with
10% of FBS, 2mM of L-glutamine (Sigma, USA) and penicillin
and streptomycin (100 U/mL; 100µg/mL) (Sigma, USA) using a
MCO-15AC incubator (Sanyo, Japan) at 5% CO2 and 37
◦C.
Rat ADSCs immunophenotype was evaluated using flow
cytometry. Cells were trypsinized using 0.25% trypsin (Sigma,
USA) and incubated in phosphate-buffered saline for 45min with
conjugated antibodies anti-CD29 (BD, USA, 556049), anti-CD44
(BioLegend, USA, 103028), anti-CD90 (SantaCruz, USA, SC-
53456), anti-CD34 (SantaCruz, USA, SC-51540), and anti-CD45
(SantaCruz, USA, SC-70686). Analysis was performed using a
Guava Easy Cyte 8HT flow cytometer (Millipore, United States).
After confirmation of the MSCs immunophenotype, ADSCs
were transduced using a recombinant lentivirus encoding
eGFP (green fluorescent protein). Transdusction efficiency was
assessed 48 h later on the basis of the number of eGFP positive
cells using an Axio Observer Z1 fluorescence microscope (Carl
Zeiss, Germany). eGFP-expressing cells were sorted using a FACS
Aria III cell sorter (BD Biosciences, USA) and expanded in
cultured until transplantation. A population of cells expressing
≥90% eGFP (ADSCs-eGFP) was used for cell transplantation.
Experiments With Animals
Experiments were conducted using 62 white Wistar rats aged 4–
6 months and weighting 200–300 g (GMBH “Nursery RAMTN,”
Moscow, Russia). For study of regeneration processes on 30 and
60th days after injury experiment was carried out on 35 male rats.
Twenty two male rats used for estimation of MSCs migration on
7 and 14th days after trauma. For obtaining of MSCs we used
5 female rats additionally. All animals were acclimatized for 2
weeks before starting the experiment. Animals were kept under
standard vivarium conditions with the day/night mode 12/12,
with free access to feed andwater. Animals were kept and used for
experimental procedures in accordance with the rules accepted
by Kazan Federal University and approved by the Local Ethics
Committee (Permit Number 5 of May 27, 2014). Animals were
used in accordance to international bioethical standards defined
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by the International guiding principles for biomedical research
involving animals (33), the EU directive 2010/63/EC and the
3Rs principles.
The autologous nerve graft (AG) was used as an experimental
nerve model. The rats were deeply anesthetized with
intraperitoneal injection of chloral hydrate solution (AppliChem,
Germany) at a dose of 400 mg/kg in the water for injections.
Surgical approach was made to the left sciatic nerve, then a
5mm long diastasis was formed by transecting the nerve with
two parallel incisions. The ends of the nerve were joined with
an autologous nerve graft, strictly maintaining the nerve fiber
growth cone, and sutured without tension with 4 Prolene 10.0
(Ethicon, USA) interrupted epineural sutures. The nerve was
then covered with 200 µL of Tissucol-Kit fibrin glue (Baxter
AG, Austria).
Stimulation of post-traumatic regeneration was achieved
through intergender allotransplantation of ADSCs-eGFP. To this
end, fibrin glue (FG) containing 1 million ADSCs-eGFP was
applied to the nerve after suturing. After nerve manipulations
the postoperative wound was closed in layers. Animals in 4
groups were compared: (1) experimental group (n = 5 on 7th,
n = 5 on 14th, n = 5 on 30th, and n = 5 on 60th days
after injury)—AG+FG+ADSCs—post-traumatic recovery by
regeneration stimulation using ADSCs-eGFP; (2) active control
group (n= 3 on 7th, n= 3 on 14th, n= 5 on 30th, and n= 5 on
60th days after injury)—AG+FG—post-traumatic recovery by
nerve coverage with fibrin glue; (3) control group (n= 3 on 7th, n
= 3 on 14th, n= 5 on 30th, and n= 5 on 60th days after injury)—
AG—post-traumatic recovery under natural conditions with a
autologous nerve graft. The animals in experimental groups were
sacrified on 7th (n= 11), 14th (n= 11), 30th (n= 5), and on 60th
(n= 5) days after injury; (4) intact group (n= 5)—intact animals
with no damage to sciatic nerve.
Antibiotics and analgesics were administered as follows:
1mL of gentamicin (25 mg/kg, Omela, Russian Federation) was
injected intramuscularly for 7 consecutive days; buprenorphine
(0.5 mg/kg) was injected subcutaneously for about 7 days after
surgery to minimize pain.
Assessment of Motor Function Recovery
To assess the grade of motor function recovery of the operated
extremity, animals of all groups underwent a functional motor
test to define the sciatic functional index (SFI) (34). The
functional test was carried out once a week on day 7, 14, 21,
28, 35, 42, 49, and 56 after the injury. To this end, a run
track with side walls was used (width−12 cm, length−45 cm,
height−15 cm) allowing a rat to move only in one direction.
Animals hind feet were covered in ink and footprints made on the
run track covered with white paper were measured to calculate
the SFI using the formula:
SFI = [((eTOF− nTOF)/nTOF)+ ((nPL− ePL)/ePL)
+ ((eTS− nTS)/nTS)+ ((eIT− nIT)/nIT)]×55, where
eTOF is the distance from the experimental foot toes to the intact
foot toes of the subsequent footprint;
nTOF is the distance from the intact foot toes to the experimental
foot toes of the subsequent footprint;
PL is the length of the footprint from the heel to the third toe of
the same foot;
TS is the distance between the first and the fifth toes of the
same foot;
IT is the distance between the second and the fourth toes of the
same foot.
All the measurements were made both for the healthy foot
footprint (n—normal) and the operated foot footprint (e—
experimental; Supplementary Figure 1).
Nerve Conduction Studies
Compound muscle action potentials (CMAPs) was used to assess
sciatic nerve conduction of the rats both before and 30 and 60
days after the surgery. Electric muscle responses were registered
using a MG-42 electromyograph (Hungary) combined with data
computer analysis. After sedation, stimulant monopolar needle
electrodes were inserted in the hip joint area and into the area of
sciatic nerve projection. Stimulation was carried out with square-
wave pulses lasting 1–2ms. Stimulus intensity varied from 0.2 to
2V. CMAP were registered by the monopolar needle electrodes
inserted into themedial gastrocnemius: cathode was inserted into
the center of the myogaster and the anode—into the tendon.
Latency of the CMAP, response threshold, duration of the CMAP,
and maximal amplitude were analyzed.
Vascularization Assessment
Recovery of blood flow in the distal part of the sciatic nerve was
assessed by the visualization of microcirculation perfusion 14 and
30 days after the surgery using a EasyLDI laser doppler (Aimago).
To this end, small operating room repetitive approach to the
sciatic nerve was carried out in the animals under intraperitoneal
narcosis. The device’s laser beam was pointed at the distal part of
the nerve and changes in microcirculation parameters over time
were analyzed using the function of perfusion unit assessment in
real time. In the evaluation process, the laser beam sequentially
scanned the tissue of the distal stump of the sciatic nerve, while
circulating red blood cells generated Doppler components in
scattered light, were picked up by a photodiode, and converted
into an electrical signal proportional to tissue perfusion at each
measurement point. The parameters were measured in absolute
perfusion units (apu) according to manufacturer’s instructions.
Material Sampling and
Morphological Assessment
Animals were sacrificed on day 7, 14, 30, and 60 after the
surgery. Early periods were used to investigate the survival rate
and migration ability of the transplanted cells. Samples collected
on day 7 and 14 after the surgery were snap-frozen in liquid
nitrogen with Neg50 Frozen Section Medium (Thermo Fisher
Scientific, USA), and transferred and stored at −80◦C. Sciatic
nerve samples were cut into 6mm thick longitudinal sections
using a Cryo-Star HM560 freezing microtome (Thermo Fisher
Scientific, USA). eGFP fluorescence was visualized using a LSM
780 laser scanning confocal microscope (Carl Zeiss, Germany).
DAPI nuclear stain was used to assess the survival rate of
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transplanted cells. Hematoxylin and eosin staining used for
estimation of morphological changes.
Late time points (day 30 and 60 after the injury the sciatic
nerve) were used to investigate post-traumatic recovery by
exposure of the L5 spinal ganglion on the operative side. Distal
parts of sciatic nerves were used to assess the number of
regenerating myelin fibers, whereas L5 spinal ganglia were used
to assess the number of surviving neurons.
The exposed distal segments of the sciatic nerve were fixed
in 2% glutaric dialdehyde, postfixed in 1% OsO4, embedded in
epoxy resin (9ml of Epon 812, 6ml of DDSA, 4ml of MNA,
and 0.2ml of DHP-30) and polymerized at 60◦C. The samples
were sliced in 2µm thick semifine cross sections using a LKB
2088 ultramicrotome (Leitz, Germany) and sections stained with
methylene blue. The number of myelin fibers was calculated by
random sample analysis of 4 nerve segments (35) using a ICC50E
light microscope (Leica, Germany) with 63×100 magnification
and oil objective immersion using the ImageJ 1.48v program.
Totally exposed left L5 spinal ganglia after laminectomy were
fixed in 4% buffered formaline and embedded in Histomix
paraffin (Biovitrum, Russia) on a Tissue-Teck R© TECTM 5
paraffin embedding station (Sakura Seiki, Japan). Paraffin
blocks were cut into longitudinal 7µm thick serial sections
on a HM340E rotary microtome (Thermo Fisher Scientific,
USA). Deparaffinized sections were stained to assess the post-
traumatic reaction of spinal ganglion neurons. Every 5th serial
section was stained with 5% azure and eosin according to
Romanovsky (Minimed, Russia) to visualize neuronal nuclei for
cell survival analysis. To assess the response of small diameter
neurons, every 5th serial section of the spinal ganglion was
stained with Isolectin-B4 fluorescence cytoplasmicmarker [lectin
from Bandeiraea simplicifolia (BSi-B4)] (IB-4) (Sigma, L2895,
1:200) and counterstained with the nuclear dye DAPI (Sigma)
before visualization.
Statistical Analysis
For all parameters of the given experimental groups, mean,
and standard deviation were calculated and data presented as
mean ± standard error of the mean (SEM). Student’s t-test,
one-way analysis of variance (ANOVA) with Tukey’s test or
two-way analysis of variance (ANOVA) were used for multiple
comparisons between all experimental and control groups.
The differences were considered significant if the probability
threshold was <0.05% (p < 0.05). Data were analyzed using the
Origin 7.0 SR0 Software (OriginLab, Northampton, MA, USA).
RESULTS
ADSCs isolated from rat adipose tissue had a fibroblast-like
morphology and high proliferative activity. They expressed
CD29, CD34, CD90 but not CD34, and CD45, confirming
their MSC phenotype (Figure 1). Established ADSC cultures
were then genetically modified to express e-GFP in order to
generate a fluorescent line for cell tracing. Fluorescent green
cells were detected 48 h after transduction and a population
of ADSCs expressing ≥90% eGFP was obtained after sorting
(Figure 2) Transplantation of fluorescent sorted cells allowed the
visualization of MSC integration in the injured area.
Examination of the sciatic nerve longitudinal sections after
transplantation demonstrated ADSCs-eGFP on the surface of
epineurium as part of the FG and in the sciatic nerve at day 7 and
14 of the autologous nerve repair. Although it was not possible to
count the absolute number of cells under the epineurium, the e-
GFP fluorescence enabled the assessment of the migration ability
of ADSCs. Cells applied in fibrin glue on the surface sciatic nerve
actively migrated under the epineurium through nerve sutures
and moved mainly retrogradely (Figures 3A,B). After 7 days,
cells migrated on average 1–2mm and cells covered 5–7mm
distance 14 days after the application. However, ADSCs were not
able to move through the intact epineurium connective tissue
(Figure 3C). No fluorescence was found in the AG+FG group
where the autologous nerve graft was covered with FG without
ADSCs (Figure 3D).
ADSCs applied together with FG on the area of the sciatic
autologous nerve graft stimulated the recovery of extremity
motor function. At the late stages, the parameters of motor
activity in the AG+FG+ADSCs group increased on average by
26% (p < 0.05) as compared to the AG group and by 28% (p <
0.05) as compared to AG+FG group (Figure 4).
Assessment of muscle bioelectric activity did not reveal
significant differences in CMAP threshold and CMAP latency
among the compared groups on the 30th and 60th days after
trauma. Initial CMAP amplitude didn’t differ between the
AG+FG+ADSCs group, the AG+FG-group, and control group.
CMAP amplitude was only 50% from initial on the 30th day after
trauma, showing axonal loss in sciatic nerve, persisting up to
60th day in both groups. The duration of CMAP in the groups
with sciatic nerve injury decreased substantially 30 days after the
injury as compared to the measurements in intact animals but at
the same time the CMAP duration was significantly higher in the
AG+FG+ADSCs group than in the AG+FG-group. Unlike the
CMAP amplitude, the CMAP duration increased and reached the
control group level in the 60 days after trauma. No differences in
CMAP duration revealed between the AG+FG+ADSCs group
and the AG+FG-group (Figure 5).
When assessing the restoration of blood supply by laser
doppler, the vascularization parameters in the AG+FG+ADSCs
group were already restored at 14 days after the injury to levels
similar to those of intact animals, whereas in the AG+FG group
the blood supply of the distal nerve segment was still decreased.
However, no difference among the groups was found after 30
days (Figure 6).
Morphological examination of the sciatic nerve longitudinal
sections revealed several changes associated with the injury
when compared to the intact nerve (Figure 7A). Myelin fibers
were found degenerated, with myelin breakdown in the area of
the autologous nerve grafting and areas close to graft oedema.
Schwann cell nuclei acquired a damaged round shape and
were displaced to the periphery of the cylinder (Figure 7B).
After transplantation, analysis of the anastomosis area revealed
migration of macrophages under the epineurium and areas of
hemorrhage with necrotic changes of small vessels (Figure 7C).
Importantly, the epineurium preserved its integrity and residues
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FIGURE 1 | Flow cytometry analysis of rat ADSCs. Green, isotype control; Red, stained cells.
FIGURE 2 | LV-eGFP transduced rat ADSCs. (A) e-GFP expression 48 h after transduction. Scale bar, 100µm. (B) Flow cytometry analysis of e-GFP 48 h after
transduction. (C) Flow cytometry analysis of e-GFP-sorted cells used for transplantation.
of fibrin glue with large-sized cells and clearly visible nuclei on its
surface were found in the AG+FG+ADSCs group (Figure 7C).
Degenerative changes spread both to central and distal directions.
Here, destructive changes were observed not only in myelin
fibers, but also in elastic fiber that acquired a denser and
more convoluted structure (Figure 7D). The transplantation of
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FIGURE 3 | Confocal miscopy images of longitudinal sections of the rat sciatic
nerve after 7 (A,C) and 14 (B) days in the AG+FG+ADSCs group and 14 days
in the AG group (D). (A,B) The area of anastomosis of sciatic nerve after 7
days (A) and 14 days (B) the penetration of ADSCs-eGFP through the suturing
area is shown. (C) The inability of ADSCs-eGFP invasion through the intact
epineurium is shown. (D) Absence of fluorescence in the AG-group is shown.
#, the needle hole; a dotted line, nerve anastomosis. The green fluorescence
indicates transplanted cells expressing e-GFP; blue fluorescence indicates cell
nuclei stained with DAPI. Scale bars: 100µm.
FIGURE 4 | Evaluation of motor function restoration of the hind extremity of
rats (Sciatic Functional Index—test). Error bars represent standard error mean.
Differences were statistically significant between the groups (*), between
groups AG+FG+ADSCs and AG; (**), between groups AG+FG+ADSCs and
AG+FG (*, **-P < 0.05, one-way ANOVA, Tukey’s test).
ADSCs with fibrin glue significantly improved the described
degenerative changes.
Myelin fibers in the distal nerve segment 30 days after
the autologous nerve grafting were represented by round
FIGURE 5 | Electroneuromyography measurements. X-axis, testing time:
before injury; 30 day and 60 day after injury. Y-axis, CMAP threshold (in volts);
CMAP amplitude (in millivolts); CMAP onset latency (in milliseconds) and
Duration of CMAP (in milliseconds). Differences were statistically significant
between the groups (*), between AG+FG+ADSCs and AG-groups; (**),
between experimental and intact groups (*, **-P < 0.05, one-way ANOVA,
Tukey’s test).
FIGURE 6 | Indicators of vascularization of the distal stump of the sciatic
nerve at 14 and 30 days after AG. Differences were statistically significant
between the groups *, between experimental groups (*P < 0.05, one-way
ANOVA, Tukey’s test).
masses with the much smaller diameter than that of
intact animals (Figures 8A,D,G). However, the number of
myelin fibers in the nerve distal segments 30 days after the
surgery in the AG+FG+ADSCs group was increased by
around 18 % (p < 0.05) compared to the AG+FG group.
The number of myelin fibers in the both groups was increased
by a further 20% 60 days after the surgery compared to day 30
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FIGURE 7 | Longitudinal sections of rat sciatic nerve. Intact nerve (n, nuclei of Schwann’s cells; v, blood vessel; mf, normal myelin fibers) is shown in (A), sciatic nerve
7 days after the operation is shown in (B–D). (B) Autotlogus nerve graft area showing degenerated myelin fibers with oedema (dmv) with degenerated nuclei of
Schwann’s cells (n). (C) Location of nerve anastomosis—central part indicated by arrow, *the needle hole, a dotted line separates epineurium from the top-located
fibrin glue with ADSCs, macrophage aggregation, necrotic altered blood vessels (nv) with a hemorrhage area, and degenerated myelin fibers (dmf) under the
epineurium. (D) Distal segment of the nerve with degenerative changes of myelin fibers (dmf) and elastic fibers (ef). Hematoxylin and eosin staining. Scale bar (A,B)
50µm, (C,D) 100µm.
(p < 0.05) (Figure 8J). The number of neurons of the L5 spinal
ganglion decreases in all groups after the injury as compared to
intact animals. The number of neurons decreased even further
by 60 days after the surgery. Although chromatolysis was visible
in the neurons 30 days after the sciatic nerve autografting
(Figures 8B,E,H), the number of neurons of the L5 spinal
ganglion was significantly higher in the AG+FG+ADSCs groups
compared to AG+FG and AG. The same increase was found 60
days after the surgery, demonstrating the regenerative capacity of
the grafted ADSCs (Figure 8K).
Assessment of the IB4+ neurons after transplantation
demonstrated that IB4 expression was found not only in small
(up to 30µm in diameter) but also in medium-sized (up
to 50µm) neurons (Figures 8C,F,I). Although, an expected
decrease in the number of IB4+ positive cells was found
in injured animals, a significant increase of IB4+ neuron
was found in the AG+FG+ADSCs group both at day 30
and day 60 after transplantation compared to the AG+FG
control group (Figure 8L).
Therefore, altogether the changes observed after autologous
transplantation demonstrated the enhanced regeneration
capacity of ADSCs in fibrin glue that resulted in motor function
recovery after injury.
DISCUSSION
Autologous nerve grafting is the gold standard procedure to
ensure nerve continuity restoration in cases of diastasis after
experimental injury induced to model neurodegenerative and
regenerative post-traumatic processes. Indeed, the autologous
conduit is biocompatibe and contains autologous Schwann
cells and extracellular matrix structural proteins contributing to
neuron survival and stimulating the regeneration of damaged
axons (36, 37). Using functional tests, electroneurophysiology
assessment, vascularization assessment, and morphometric study
of the sciatic nerve and L5 spinal ganglion, in this study we were
able to confirm that surgery aimed at approximating the ends of
an injured nerve is not enough to achieve complete regeneration.
Therefore, regeneration stimulation by means of application
of autologous ADSCs to the area of nerve injury allowed a
significant enhancement of regeneration through stimulation of
angiogenesis and neuroprotection.
The rate and degree of nerve fiber de- and regeneration
after damage is a complex process associated with inflammation,
adhesion, regulation of neurotrophic factors, neurotransmitter
synthesis and release, formation of the nerve growth cone,
neuron survival, growth of axons and myelination, and many
other factors (38, 39). At the same time, immune reactions taking
place in the injury area cause the expression of pro-inflammatory
transmitters around the damaged tissue and contribute to the
development of scar tissue, nerve fibrosis (40), neuromas, and
hyperplasia which impact on nerve damage and on conduction
restoration after injury (41).
During nerve fiber regeneration the central segment of
the neuronal axon interacts with glial components and grows
according to the concentration gradient of chemical factors
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FIGURE 8 | Morphology and number of fibers and neurons in intact and transplanted animals. Top line (A–C), intact animals; second line (D–F), AG + FG + ADSCs
group 30 days after the injury; third line (G–I), AG + FG group 30 days after the injury. Scale bar scale 50µm. (A,D,G) Light microscopy images of myelinated fibers
fixed in osmium and stained by methylene blue. (B,E,H) Light microscopy images of L5 DRG neurons stained by azure-eosin. (C,F,I) Confocal microscopy images of
IB-4+ neurons stained with the fluorescent cytoplasmic marker Isolectin-B4 [lectin from Bandeiraea simplicifolia (BSi-B4)]. (J) Number of myelin fibers in the distal
stump of the sciatic nerve; (K) Number of L5 DRG neurons; (L) Number of IB-4+ neurons L5 DRG. Differences were statistically significant between the groups (*)
between experimental groups, (**) between intact and experimental groups (*, **-P < 0.05, one-way ANOVA, Tukey’s test).
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against the background of reactive changes in the sensory
neurons and degenerative processes in the peripheral segment
of the nerve. The success of reinnervation depends on the
ability of axons to reach their target organ. It is known that the
sciatic nerve is comprised of processes of motor and sensory
neurons with trophic function. If there is no contact with the
axon, Schwann cells activate the synthesis of neurotrophic factors
such as nerve growth factor (NGF), fibroblast growth factor
(bFGF), and the ciliary neurotrophic factor (CNTF) (42, 43).
These factors, together with ATP and neuregulin released from
the proximal nerve ends (44, 45) promote the formation of new
Schwann cells (46) and, together with acetylcholine, stimulate
their further proliferation (47).
Functional stimulation of the innervated area stops when the
sciatic nerve is transected, and the secretion or action of co-
transmitters and trophogens is increased (48). From the survival
of neurons directly depends on the speed and quality of recovery
of the motor and sensitive function of the injured extremity.
We demonstrate that on days 7 and 14, the recovery of motor
function in the AG+FG+ADSCs and AG+FG groups is lower
than in the AG group, however, it is very early to talk about any
therapeutic effect on these periods. This fact at this time is due
to the mechanical effect of FG on the sciatic nerve. Normally,
the sciatic nerve passes freely between the muscles, and the
placement of fibrin glue on its surface leads to its adhesion to the
muscles, creating the effect of scarring. The result of the influence
of the ADSCs observed in 14 days after the injury, when the cells
that have penetrated into the nerve thickness begin to show their
therapeutic effect. Neuron regenerative potential is preserved 2
to 15 days after nerve transection and up to several months after
nerve crush. This interval is believed to be the most favorable for
regeneration stimulation and support of neuron survival (49, 50).
Absolute difference in CMAP duration between
AG+FG+ADSCs and AG+FG groups is not big despite
statistical significance that rise the question of biological
meaning of this observation. But they correspond with higher
results of motor activity in AG+FG+ADSCs group from 21 to
35 days after trauma. Therefore, we suppose that this difference
reflects higher amount of motor axons of sciatic nerve in
AG+FG+ADSCs group.
Therefore, the assessment of the number of spinal ganglion
neurons after the injury is essential for understanding the
mechanisms of spontaneous sciatic nerve regeneration,
estimation of quality of surgical procedures aimed at nerve
structure restoration, and methods of stimulation of post-
traumatic regeneration. L4-L5 spinal ganglia contain 98–99% of
nerve cell bodies whose axons form the rat sciatic nerve (51). It
is known that sciatic nerve axotomy results in the death of spinal
ganglion neurons (52–55) and we demonstrated low neuron
survival rate in the L5 spinal ganglion up to day 60 after the
injury. When assessing the total neuron count, it was found that
small diameter pain neurons are more vulnerable.
We showed that after sciatic nerve injury IB4 expression is
found not only in small pain neurons but also in medium-sized
neurons. IB4 is believed to be a marker of small nociceptive
neurons that have unmyelinated processes in the sciatic nerve
innervating the epidermis and showing lower survival both
in vitro and in vivo (56). Therefore, this type of neurons is
more prone to cell death as compared to medium and large
diameter neurons, which is consistent with our results. Sensory
IB-4+ neurons are less flexible and grow worse after axotomy.
After sciatic nerve injury, IB4 neuron terminal axons can show
retraction (57) and have substantially lower regeneration ability
(58). It is therefore likely that IB4 expression in some medium
diameter neurons after nerve injury could be due to axon
growth inhibition.
Although molecular mechanisms underlying the death of
spinal ganglion neurons in response to nerve axotomy are
not fully understood, there is enough evidence of the role
played by injury severity on neuron apoptosis and potential
ability of axons to grow to respective distal receptors (59).
Exogenous trophic factors can counteract the post-traumatic
death of sensory neurons. Transplanted ADSCs may produce
neurotrophic factors as cells transplanted into the nerve show
retrograde neuroprotective effect on respective sensory neurons
(52, 53). The beneficial effect of cell therapy can be seen in
as little as the first week after the surgery (60). Therefore, it
can be speculated that the presence in an injured nerve of
exogenous progenitor cells with high paracrine activity in the first
several days after the injury promotes axon growth and survival.
Indeed, we did observe a significant increase in the number of
myelin fibers L5 and IB4+ neurons after ADSCs transplantation,
suggesting a trophic action of MSCs after injury.
In addition, morphological assessment of nerve structure at
early stages after the injury revealed inflammation both in groups
with cell stimulation and in control groups. The severity of
inflammation was, however, much lower in the group treated
with ADSCs.
In order to assess the extent of regeneration and its clinical
relevance, we performed functional tests as the examination of
morphological changes in the injured sciatic nerve often showed
discrepancy between histopathological changes and functional
observations (61).
We showed that nerve reconstruction by means of autologous
nerve repair considerably reduces the ability of the operated
extremity to move. It may be that nerve injuries go hand in hand
with neuropathic pain (62) but we demonstrated that ADSCs can
induce a significant increase in the sciatic functional index and
associated motor function recovery.
Several studies demonstrated that transplanted MSCs can
directly influence angiogenesis by influencing all the stages of
vessel formation and maturation (63). Indeed, MSCs secrete
cytokines and growth factors stimulating survival, growth, and
differentiation of vascular endothelium (64), thus preventing the
formation of neurotrophic ulcers caused by vessel destruction
and ischemia. It is likely that the restoration of blood flow
in the operated sciatic nerve could be associated with the
activation of proangiogenic factor expression by transplanted
ADSCs, such as fibroblast growth factor and endothelial growth
factor (65, 66).
With the help of nerve conduction studies, we were able
to assess the functioning of sciatic nerve motor fibers. Since
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fast-conducting fibers, such as axons of motor neurons (type
Aα) and afferent muscle fibers (type Aβ), are thicker than
slow-conducting, the process of their recovery takes more time.
Unmyelinated neuron axons (type C), such as axons of the spinal
ganglion sensory neurons, involved in the transmission of pain
(67), temperature, and postganglionic sympathethic transmission
are the slowest ones (68). Decreased amplitude and shortened
CMAP duration by day 30 reflected the loss of sciatic nerve axons,
most probably due to wallerian degeneration. In the period from
day 30 to day 60 no increase in the CMAP amplitude was
registered but the CMAP duration increased, thus demonstrating
the increasing number of functionally active axons in the
experimental and control groups. These changes also evidenced
incomplete remyelination of regenerated axons and subsequent
CMAP dispersion, which at early stages of re-innervation
caused increased CMAP duration with unchanged amplitude.
Significantly longer CMAP duration in the experimental group
as compared to the control group by day 30 could be a sign of
earlier regeneration under the influence of ADSCs, which is in
line with the data we obtained for the number of myelin fibers
in the distal nerve segment. The number of myelin fibers in the
distal sciatic nerve segment increased in all studied groups but
this parameter was higher in the group with ADSCs.
Altogether, our morphological and functional data
demonstrate the beneficial effect of cell therapy with ADSCs.
ADSCs transplanted with FG which facilitate the joining of
the segments of the transected sciatic nerve, entered under
the epineurium through the junctions of nerve segments,
directionally migrated predominantly retrogradely, contributed
to the sensory neurons survival through stimulating the growth
of their axons, and promoted conduit vascularization by
restoring the motor function of the injured extremity.
We cannot rule out a possible transdifferentiation of ADSCs
into Schwann cells which could be responsible for the augmented
regeneration observed; this possibility, however, warrants further
investigation. Taking into account that Schwann cells play a key
role in peripheral nerve survival and functioning (68), we believe
that transplantation of ADSCs provides the optimal conditions
for regeneration. Importantly, cell transplantation should be
carried out in the acute traumatic period with minimally invasive
delivery by application of potential regeneration stimulants as
part of fibrin glue in order to achieve effective repair of peripheral
nerve damage.
CONCLUSION
Our data suggest that MSCs transplanted in fibrin glue to the
place of nerve injury have a neuroprotective effect on DRG
L5 sensory neurons, stimulate axon growth, and myelination.
We propose a new method of MSCs delivery to the area of
traumatic injury by using fibrin glue. This method of delivery
of regeneration stimulants could be beneficial for the successful
treatment peripheral nerves injuries and easily translate to
the clinical practice.
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